Drug name

Repaglinide tablets

Ingredients

Repaglinide

Description

White to off-white pill

Introduction

Repaglinide tablet is a non-sulfonylurea insulin secretor for the treatment of type 2 diabetes patients. It was launched in China in 2000 and is a Class B drug in the national medical insurance catalog.

Indications

It is suitable for type 2 diabetes whose blood sugar cannot be adequately controlled by diet control, exercise therapy and weight loss.

Specification

0.5mg

Dosage and Administration

Usually take this medicine within 15 minutes before meals，but can also be taken within 0-30 minutes before meals (e.g., 2,3,4 meals a day). Patients who miss a meal (or additional meal) should reduce (or increase) one dose of medicine accordingly.

Shelf life

24 months